Supplementum 01/2019 Imunoterapie
RNDr. Jan Ženka, CSc.
Katedra medicínské biologie, Přírodovědecká fakulta JU, České Budějovice
Intratumoral immunotherapy is based on the use of autologous tumor as a vaccine. Direct injection of small amount of immunostimulators into the tumor creates effective concentrations in situ and decreases their side effects. Our therapeutic approach amplifies the primary effect of innate immunity and creates favourable conditions for involvement of adaptive immunity.
intratumoral immunotherapy, melanoma, pancreatic adenocarcinoma
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...